|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PGA3-CTSE (FusionGDB2 ID:64089) |
Fusion Gene Summary for PGA3-CTSE |
Fusion gene summary |
Fusion gene information | Fusion gene name: PGA3-CTSE | Fusion gene ID: 64089 | Hgene | Tgene | Gene symbol | PGA3 | CTSE | Gene ID | 643834 | 1510 |
Gene name | pepsinogen A3 | cathepsin E | |
Synonyms | - | CATE | |
Cytomap | 11q12.2 | 1q32.1 | |
Type of gene | protein-coding | protein-coding | |
Description | pepsin A-3pepsinogen 3, group I (pepsinogen A)pepsinogen-3 | cathepsin Eerythrocyte membrane aspartic proteinaseslow-moving proteinase | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | P14091 | |
Ensembl transtripts involved in fusion gene | ENST00000325558, ENST00000543125, ENST00000538258, | ENST00000361052, ENST00000358184, ENST00000360218, ENST00000432969, ENST00000468617, | |
Fusion gene scores | * DoF score | 15 X 13 X 4=780 | 3 X 3 X 2=18 |
# samples | 16 | 3 | |
** MAII score | log2(16/780*10)=-2.28540221886225 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: PGA3 [Title/Abstract] AND CTSE [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PGA3(60971741)-CTSE(206319100), # samples:9 CTSE(206318467)-PGA3(60973981), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | PGA3-CTSE seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. PGA3-CTSE seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | CTSE | GO:0006508 | proteolysis | 16997486 |
Tgene | CTSE | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 8765029 |
Fusion gene breakpoints across PGA3 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CTSE (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | TCGA-L5-A4OJ-11A | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
ChimerDB4 | Non-Cancer | TCGA-L5-A4OJ-11A | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
ChimerDB4 | Non-Cancer | TCGA-BR-8060-11A | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
ChimerDB4 | Non-Cancer | 139N | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
ChimerDB4 | Non-Cancer | 203N | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
ChimerDB4 | Non-Cancer | 267N | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
ChimerDB4 | Non-Cancer | 43N | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
ChimerDB4 | Non-Cancer | 5263N | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
ChimerDB4 | Non-Cancer | 5357N | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
ChimerDB4 | Non-Cancer | 5381N | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
ChimerDB4 | Non-Cancer | 5759N | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
Top |
Fusion Gene ORF analysis for PGA3-CTSE |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000325558 | ENST00000361052 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
Frame-shift | ENST00000325558 | ENST00000358184 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
Frame-shift | ENST00000325558 | ENST00000360218 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
Frame-shift | ENST00000325558 | ENST00000432969 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
5CDS-intron | ENST00000325558 | ENST00000468617 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
Frame-shift | ENST00000543125 | ENST00000361052 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
Frame-shift | ENST00000543125 | ENST00000358184 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
Frame-shift | ENST00000543125 | ENST00000360218 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
Frame-shift | ENST00000543125 | ENST00000432969 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
5CDS-intron | ENST00000543125 | ENST00000468617 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
Frame-shift | ENST00000538258 | ENST00000361052 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
Frame-shift | ENST00000538258 | ENST00000358184 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
Frame-shift | ENST00000538258 | ENST00000360218 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
Frame-shift | ENST00000538258 | ENST00000432969 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
5CDS-intron | ENST00000538258 | ENST00000468617 | PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + |
In-frame | ENST00000325558 | ENST00000361052 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
In-frame | ENST00000325558 | ENST00000358184 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
In-frame | ENST00000325558 | ENST00000360218 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
In-frame | ENST00000325558 | ENST00000432969 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
5CDS-intron | ENST00000325558 | ENST00000468617 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
intron-3CDS | ENST00000543125 | ENST00000361052 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
intron-3CDS | ENST00000543125 | ENST00000358184 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
intron-3CDS | ENST00000543125 | ENST00000360218 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
intron-3CDS | ENST00000543125 | ENST00000432969 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
intron-intron | ENST00000543125 | ENST00000468617 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
intron-3CDS | ENST00000538258 | ENST00000361052 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
intron-3CDS | ENST00000538258 | ENST00000358184 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
intron-3CDS | ENST00000538258 | ENST00000360218 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
intron-3CDS | ENST00000538258 | ENST00000432969 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
intron-intron | ENST00000538258 | ENST00000468617 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000325558 | PGA3 | chr11 | 60971741 | + | ENST00000361052 | CTSE | chr1 | 206319100 | + | 2304 | 404 | 131 | 1384 | 417 |
ENST00000325558 | PGA3 | chr11 | 60971741 | + | ENST00000358184 | CTSE | chr1 | 206319100 | + | 2289 | 404 | 131 | 1369 | 412 |
ENST00000325558 | PGA3 | chr11 | 60971741 | + | ENST00000360218 | CTSE | chr1 | 206319100 | + | 2146 | 404 | 131 | 1270 | 379 |
ENST00000325558 | PGA3 | chr11 | 60971741 | + | ENST00000432969 | CTSE | chr1 | 206319100 | + | 1603 | 404 | 131 | 1270 | 379 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000325558 | ENST00000361052 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + | 0.00066042 | 0.9993395 |
ENST00000325558 | ENST00000358184 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + | 0.000650687 | 0.9993493 |
ENST00000325558 | ENST00000360218 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + | 0.004885117 | 0.9951149 |
ENST00000325558 | ENST00000432969 | PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + | 0.009075576 | 0.9909244 |
Top |
Fusion Genomic Features for PGA3-CTSE |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + | 0.99983203 | 0.000167916 |
PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + | 0.00012887 | 0.99987113 |
PGA3 | chr11 | 60978907 | + | CTSE | chr1 | 206331020 | + | 0.99983203 | 0.000167916 |
PGA3 | chr11 | 60971741 | + | CTSE | chr1 | 206319100 | + | 0.00012887 | 0.99987113 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for PGA3-CTSE |
Go to FGviewer for the breakpoints of chr11:60971741-chr1:206319100 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | CTSE |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: May have a role in immune function. Probably involved in the processing of antigenic peptides during MHC class II-mediated antigen presentation. May play a role in activation-induced lymphocyte depletion in the thymus, and in neuronal degeneration and glial cell activation in the brain. {ECO:0000269|PubMed:8765029}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | CTSE | chr11:60971741 | chr1:206319100 | ENST00000358184 | 1 | 9 | 78_396 | 75.0 | 397.0 | Domain | Peptidase A1 | |
Tgene | CTSE | chr11:60971741 | chr1:206319100 | ENST00000360218 | 1 | 8 | 78_396 | 75.0 | 364.0 | Domain | Peptidase A1 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PGA3 | chr11:60971741 | chr1:206319100 | ENST00000325558 | + | 2 | 9 | 76_385 | 73.0 | 389.0 | Domain | Peptidase A1 |
Top |
Fusion Gene Sequence for PGA3-CTSE |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000325558_ENST00000361052_TCGA-BR-8060-11A_PGA3_chr11_60971741_+_CTSE_chr1_206319100_length(transcript)=2304nt_BP=404nt TCAGAATGTGGCTTAGGGCAGCCACAATCTTATCAGGAGCTTCTCTGTTTGGGATCAGGGGAACCGGTGACTTTCAGAGGCCGATAAGGC GGGACCCAACTTGTATATAAGGGGCAGCTCATGCTGCTGCTCTGCACCTTCCTCCCGTCTTGCCTTCTCCCTCGAGTTGGGACCCGGGAA GAACCATGAAGTGGCTGCTGCTGCTGGGTCTGGTGGCACTCTCTGAGTGCATCATGTACAAGGTCCCCCTCATCAGAAAGAAGTCCTTGA GGCGCACCCTGTCCGAGCGTGGCCTGCTGAAGGACTTCCTGAAGAAGCACAACCTCAACCCAGCCAGAAAGTACTTCCCCCAGTGGAAGG CTCCCACCCTGGTAGATGAACAGCCCCTGGAGAACTACCTGGATATGGAATACTTCGGCACTATCTCCATTGGCTCCCCACCACAGAACT TCACTGTCATCTTCGACACTGGCTCCTCCAACCTCTGGGTCCCCTCTGTGTACTGCACTAGCCCAGCCTGCAAGACGCACAGCAGGTTCC AGCCTTCCCAGTCCAGCACATACAGCCAGCCAGGTCAATCTTTCTCCATTCAGTATGGAACCGGGAGCTTGTCCGGGATCATTGGAGCCG ACCAAGTCTCTGCTTTCTCCTACCAGGTGGAAGGACTAACCGTGGTTGGCCAGCAGTTTGGAGAAAGTGTCACAGAGCCAGGCCAGACCT TTGTGGATGCAGAGTTTGATGGAATTCTGGGCCTGGGATACCCCTCCTTGGCTGTGGGAGGAGTGACTCCAGTATTTGACAACATGATGG CTCAGAACCTGGTGGACTTGCCGATGTTTTCTGTCTACATGAGCAGTAACCCAGAAGGTGGTGCGGGGAGCGAGCTGATTTTTGGAGGCT ACGACCACTCCCATTTCTCTGGGAGCCTGAATTGGGTCCCAGTCACCAAGCAAGCTTACTGGCAGATTGCACTGGATAACATCCAGGTGG GAGGCACTGTTATGTTCTGCTCCGAGGGCTGCCAGGCCATTGTGGACACAGGGACTTCCCTCATCACTGGCCCTTCCGACAAGATTAAGC AGCTGCAAAACGCCATTGGGGCAGCCCCCGTGGATGGAGAATATGCTGTGGAGTGTGCCAACCTTAACGTCATGCCGGATGTCACCTTCA CCATTAACGGAGTCCCCTATACCCTCAGCCCAACTGCCTACACCCTACTGGACTTCGTGGATGGAATGCAGTTCTGCAGCAGTGGCTTTC AAGGACTTGACATCCACCCTCCAGCTGGGCCCCTCTGGATCCTGGGGGATGTCTTCATTCGACAGTTTTACTCAGTCTTTGACCGTGGGA ATAACCGTGTGGGACTGGCCCCAGCAGTCCCCTAAGGAGGGGCCTTGTGTCTGTGCCTGCCTGTCTGACAGACCTTGAATATGTTAGGCT GGGGCATTCTTTACACCTACAAAAAGTTATTTTCCAGAGAATGTAGCTGTTTCCAGGGTTGCAACTTGAATTAAGACCAAACAGAACATG AGAATACACACACACACACACATATACACACACACACACTTCACACATACACACCACTCCCACCACCGTCATGATGGAGGAATTACGTTA TACATTCATATTTTGTATTGATTTTTGATTATGAAAATCAAAAATTTTCACATTTGATTATGAAAATCTCCAAACATATGCACAAGCAGA GATCATGGTATAATAAATCCCTTTGCAACTCCACTCAGCCCTGACAACCCATCCACACACGGCCAGGCCTGTTTATCTACACTGCTGCCC ACTCCTCTCTCCAGCTCCACATGCTGTACCTGGATCATTCTGAAGCAAATTCCGAGCATTACATCATTTTGTCCATAAATATTTCTAACA TCCTTAAATATACAATCGGAATTCAAGCATCTCCCATTGTCCCACAAATGTTTGGCTGTTTTTGTAGTTGGATTGTTTGTATTAGGATTC AAGCAAGGCCCATATATTGCATTTATTTGAAATGTCTGTAAGTCTCTTTCCATCTACAGAGTTTAGCACATTTGAACGTTGCTGGTTGAA ATCCCGAGGTGTCATTTGACATGGTTCTCTGAACTTATCTTTCCTATAAAATGGTAGTTAGATCTGGAGGTCTGATTTTGTGGCAAAAAT ACTTCCTAGGTGGTGCTGGGTACTTCTTGTTGCATCCTGTCAGGAGGCAGATAATGCTGGTGCCTCTCTATTGGTAATGTTAAGACTGCT >In-frame_ENST00000325558_ENST00000361052_TCGA-BR-8060-11A_PGA3_chr11_60971741_+_CTSE_chr1_206319100_length(amino acids)=417AA_start in transcript=131_stop in transcript=1384 MHLPPVLPSPSSWDPGRTMKWLLLLGLVALSECIMYKVPLIRKKSLRRTLSERGLLKDFLKKHNLNPARKYFPQWKAPTLVDEQPLENYL DMEYFGTISIGSPPQNFTVIFDTGSSNLWVPSVYCTSPACKTHSRFQPSQSSTYSQPGQSFSIQYGTGSLSGIIGADQVSAFSYQVEGLT VVGQQFGESVTEPGQTFVDAEFDGILGLGYPSLAVGGVTPVFDNMMAQNLVDLPMFSVYMSSNPEGGAGSELIFGGYDHSHFSGSLNWVP VTKQAYWQIALDNIQVGGTVMFCSEGCQAIVDTGTSLITGPSDKIKQLQNAIGAAPVDGEYAVECANLNVMPDVTFTINGVPYTLSPTAY -------------------------------------------------------------- >In-frame_ENST00000325558_ENST00000358184_TCGA-BR-8060-11A_PGA3_chr11_60971741_+_CTSE_chr1_206319100_length(transcript)=2289nt_BP=404nt TCAGAATGTGGCTTAGGGCAGCCACAATCTTATCAGGAGCTTCTCTGTTTGGGATCAGGGGAACCGGTGACTTTCAGAGGCCGATAAGGC GGGACCCAACTTGTATATAAGGGGCAGCTCATGCTGCTGCTCTGCACCTTCCTCCCGTCTTGCCTTCTCCCTCGAGTTGGGACCCGGGAA GAACCATGAAGTGGCTGCTGCTGCTGGGTCTGGTGGCACTCTCTGAGTGCATCATGTACAAGGTCCCCCTCATCAGAAAGAAGTCCTTGA GGCGCACCCTGTCCGAGCGTGGCCTGCTGAAGGACTTCCTGAAGAAGCACAACCTCAACCCAGCCAGAAAGTACTTCCCCCAGTGGAAGG CTCCCACCCTGGTAGATGAACAGCCCCTGGAGAACTACCTGGATATGGAATACTTCGGCACTATCTCCATTGGCTCCCCACCACAGAACT TCACTGTCATCTTCGACACTGGCTCCTCCAACCTCTGGGTCCCCTCTGTGTACTGCACTAGCCCAGCCTGCAAGACGCACAGCAGGTTCC AGCCTTCCCAGTCCAGCACATACAGCCAGCCAGGTCAATCTTTCTCCATTCAGTATGGAACCGGGAGCTTGTCCGGGATCATTGGAGCCG ACCAAGTCTCTGTGGAAGGACTAACCGTGGTTGGCCAGCAGTTTGGAGAAAGTGTCACAGAGCCAGGCCAGACCTTTGTGGATGCAGAGT TTGATGGAATTCTGGGCCTGGGATACCCCTCCTTGGCTGTGGGAGGAGTGACTCCAGTATTTGACAACATGATGGCTCAGAACCTGGTGG ACTTGCCGATGTTTTCTGTCTACATGAGCAGTAACCCAGAAGGTGGTGCGGGGAGCGAGCTGATTTTTGGAGGCTACGACCACTCCCATT TCTCTGGGAGCCTGAATTGGGTCCCAGTCACCAAGCAAGCTTACTGGCAGATTGCACTGGATAACATCCAGGTGGGAGGCACTGTTATGT TCTGCTCCGAGGGCTGCCAGGCCATTGTGGACACAGGGACTTCCCTCATCACTGGCCCTTCCGACAAGATTAAGCAGCTGCAAAACGCCA TTGGGGCAGCCCCCGTGGATGGAGAATATGCTGTGGAGTGTGCCAACCTTAACGTCATGCCGGATGTCACCTTCACCATTAACGGAGTCC CCTATACCCTCAGCCCAACTGCCTACACCCTACTGGACTTCGTGGATGGAATGCAGTTCTGCAGCAGTGGCTTTCAAGGACTTGACATCC ACCCTCCAGCTGGGCCCCTCTGGATCCTGGGGGATGTCTTCATTCGACAGTTTTACTCAGTCTTTGACCGTGGGAATAACCGTGTGGGAC TGGCCCCAGCAGTCCCCTAAGGAGGGGCCTTGTGTCTGTGCCTGCCTGTCTGACAGACCTTGAATATGTTAGGCTGGGGCATTCTTTACA CCTACAAAAAGTTATTTTCCAGAGAATGTAGCTGTTTCCAGGGTTGCAACTTGAATTAAGACCAAACAGAACATGAGAATACACACACAC ACACACATATACACACACACACACTTCACACATACACACCACTCCCACCACCGTCATGATGGAGGAATTACGTTATACATTCATATTTTG TATTGATTTTTGATTATGAAAATCAAAAATTTTCACATTTGATTATGAAAATCTCCAAACATATGCACAAGCAGAGATCATGGTATAATA AATCCCTTTGCAACTCCACTCAGCCCTGACAACCCATCCACACACGGCCAGGCCTGTTTATCTACACTGCTGCCCACTCCTCTCTCCAGC TCCACATGCTGTACCTGGATCATTCTGAAGCAAATTCCGAGCATTACATCATTTTGTCCATAAATATTTCTAACATCCTTAAATATACAA TCGGAATTCAAGCATCTCCCATTGTCCCACAAATGTTTGGCTGTTTTTGTAGTTGGATTGTTTGTATTAGGATTCAAGCAAGGCCCATAT ATTGCATTTATTTGAAATGTCTGTAAGTCTCTTTCCATCTACAGAGTTTAGCACATTTGAACGTTGCTGGTTGAAATCCCGAGGTGTCAT TTGACATGGTTCTCTGAACTTATCTTTCCTATAAAATGGTAGTTAGATCTGGAGGTCTGATTTTGTGGCAAAAATACTTCCTAGGTGGTG CTGGGTACTTCTTGTTGCATCCTGTCAGGAGGCAGATAATGCTGGTGCCTCTCTATTGGTAATGTTAAGACTGCTGGGTGGGTTTGGAGT >In-frame_ENST00000325558_ENST00000358184_TCGA-BR-8060-11A_PGA3_chr11_60971741_+_CTSE_chr1_206319100_length(amino acids)=412AA_start in transcript=131_stop in transcript=1369 MHLPPVLPSPSSWDPGRTMKWLLLLGLVALSECIMYKVPLIRKKSLRRTLSERGLLKDFLKKHNLNPARKYFPQWKAPTLVDEQPLENYL DMEYFGTISIGSPPQNFTVIFDTGSSNLWVPSVYCTSPACKTHSRFQPSQSSTYSQPGQSFSIQYGTGSLSGIIGADQVSVEGLTVVGQQ FGESVTEPGQTFVDAEFDGILGLGYPSLAVGGVTPVFDNMMAQNLVDLPMFSVYMSSNPEGGAGSELIFGGYDHSHFSGSLNWVPVTKQA YWQIALDNIQVGGTVMFCSEGCQAIVDTGTSLITGPSDKIKQLQNAIGAAPVDGEYAVECANLNVMPDVTFTINGVPYTLSPTAYTLLDF -------------------------------------------------------------- >In-frame_ENST00000325558_ENST00000360218_TCGA-BR-8060-11A_PGA3_chr11_60971741_+_CTSE_chr1_206319100_length(transcript)=2146nt_BP=404nt TCAGAATGTGGCTTAGGGCAGCCACAATCTTATCAGGAGCTTCTCTGTTTGGGATCAGGGGAACCGGTGACTTTCAGAGGCCGATAAGGC GGGACCCAACTTGTATATAAGGGGCAGCTCATGCTGCTGCTCTGCACCTTCCTCCCGTCTTGCCTTCTCCCTCGAGTTGGGACCCGGGAA GAACCATGAAGTGGCTGCTGCTGCTGGGTCTGGTGGCACTCTCTGAGTGCATCATGTACAAGGTCCCCCTCATCAGAAAGAAGTCCTTGA GGCGCACCCTGTCCGAGCGTGGCCTGCTGAAGGACTTCCTGAAGAAGCACAACCTCAACCCAGCCAGAAAGTACTTCCCCCAGTGGAAGG CTCCCACCCTGGTAGATGAACAGCCCCTGGAGAACTACCTGGATATGGAATACTTCGGCACTATCTCCATTGGCTCCCCACCACAGAACT TCACTGTCATCTTCGACACTGGCTCCTCCAACCTCTGGGTCCCCTCTGTGTACTGCACTAGCCCAGCCTGCAAGACGCACAGCAGGTTCC AGCCTTCCCAGTCCAGCACATACAGCCAGCCAGGTCAATCTTTCTCCATTCAGTATGGAACCGGGAGCTTGTCCGGGATCATTGGAGCCG ACCAAGTCTCTGTGGAAGGACTAACCGTGGTTGGCCAGCAGTTTGGAGAAAGTGTCACAGAGCCAGGCCAGACCTTTGTGGATGCAGAGT TTGATGGAATTCTGGGCCTGGGATACCCCTCCTTGGCTGTGGGAGGAGTGACTCCAGTATTTGACAACATGATGGCTCAGAACCTGGTGG ACTTGCCGATGTTTTCTGTCTACATGAGCAGTAACCCAGAAGGTGGTGCGGGGAGCGAGCTGATTTTTGGAGGCTACGACCACTCCCATT TCTCTGGGAGCCTGAATTGGGTCCCAGTCACCAAGCAAGCTTACTGGCAGATTGCACTGGATAATATGCTGTGGAGTGTGCCAACCTTAA CGTCATGCCGGATGTCACCTTCACCATTAACGGAGTCCCCTATACCCTCAGCCCAACTGCCTACACCCTACTGGACTTCGTGGATGGAAT GCAGTTCTGCAGCAGTGGCTTTCAAGGACTTGACATCCACCCTCCAGCTGGGCCCCTCTGGATCCTGGGGGATGTCTTCATTCGACAGTT TTACTCAGTCTTTGACCGTGGGAATAACCGTGTGGGACTGGCCCCAGCAGTCCCCTAAGGAGGGGCCTTGTGTCTGTGCCTGCCTGTCTG ACAGACCTTGAATATGTTAGGCTGGGGCATTCTTTACACCTACAAAAAGTTATTTTCCAGAGAATGTAGCTGTTTCCAGGGTTGCAACTT GAATTAAGACCAAACAGAACATGAGAATACACACACACACACACATATACACACACACACACTTCACACATACACACCACTCCCACCACC GTCATGATGGAGGAATTACGTTATACATTCATATTTTGTATTGATTTTTGATTATGAAAATCAAAAATTTTCACATTTGATTATGAAAAT CTCCAAACATATGCACAAGCAGAGATCATGGTATAATAAATCCCTTTGCAACTCCACTCAGCCCTGACAACCCATCCACACACGGCCAGG CCTGTTTATCTACACTGCTGCCCACTCCTCTCTCCAGCTCCACATGCTGTACCTGGATCATTCTGAAGCAAATTCCGAGCATTACATCAT TTTGTCCATAAATATTTCTAACATCCTTAAATATACAATCGGAATTCAAGCATCTCCCATTGTCCCACAAATGTTTGGCTGTTTTTGTAG TTGGATTGTTTGTATTAGGATTCAAGCAAGGCCCATATATTGCATTTATTTGAAATGTCTGTAAGTCTCTTTCCATCTACAGAGTTTAGC ACATTTGAACGTTGCTGGTTGAAATCCCGAGGTGTCATTTGACATGGTTCTCTGAACTTATCTTTCCTATAAAATGGTAGTTAGATCTGG AGGTCTGATTTTGTGGCAAAAATACTTCCTAGGTGGTGCTGGGTACTTCTTGTTGCATCCTGTCAGGAGGCAGATAATGCTGGTGCCTCT >In-frame_ENST00000325558_ENST00000360218_TCGA-BR-8060-11A_PGA3_chr11_60971741_+_CTSE_chr1_206319100_length(amino acids)=379AA_start in transcript=131_stop in transcript=1270 MHLPPVLPSPSSWDPGRTMKWLLLLGLVALSECIMYKVPLIRKKSLRRTLSERGLLKDFLKKHNLNPARKYFPQWKAPTLVDEQPLENYL DMEYFGTISIGSPPQNFTVIFDTGSSNLWVPSVYCTSPACKTHSRFQPSQSSTYSQPGQSFSIQYGTGSLSGIIGADQVSVEGLTVVGQQ FGESVTEPGQTFVDAEFDGILGLGYPSLAVGGVTPVFDNMMAQNLVDLPMFSVYMSSNPEGGAGSELIFGGYDHSHFSGSLNWVPVTKQA YWQIALDNMLWSVPTLTSCRMSPSPLTESPIPSAQLPTPYWTSWMECSSAAVAFKDLTSTLQLGPSGSWGMSSFDSFTQSLTVGITVWDW -------------------------------------------------------------- >In-frame_ENST00000325558_ENST00000432969_TCGA-BR-8060-11A_PGA3_chr11_60971741_+_CTSE_chr1_206319100_length(transcript)=1603nt_BP=404nt TCAGAATGTGGCTTAGGGCAGCCACAATCTTATCAGGAGCTTCTCTGTTTGGGATCAGGGGAACCGGTGACTTTCAGAGGCCGATAAGGC GGGACCCAACTTGTATATAAGGGGCAGCTCATGCTGCTGCTCTGCACCTTCCTCCCGTCTTGCCTTCTCCCTCGAGTTGGGACCCGGGAA GAACCATGAAGTGGCTGCTGCTGCTGGGTCTGGTGGCACTCTCTGAGTGCATCATGTACAAGGTCCCCCTCATCAGAAAGAAGTCCTTGA GGCGCACCCTGTCCGAGCGTGGCCTGCTGAAGGACTTCCTGAAGAAGCACAACCTCAACCCAGCCAGAAAGTACTTCCCCCAGTGGAAGG CTCCCACCCTGGTAGATGAACAGCCCCTGGAGAACTACCTGGATATGGAATACTTCGGCACTATCTCCATTGGCTCCCCACCACAGAACT TCACTGTCATCTTCGACACTGGCTCCTCCAACCTCTGGGTCCCCTCTGTGTACTGCACTAGCCCAGCCTGCAAGACGCACAGCAGGTTCC AGCCTTCCCAGTCCAGCACATACAGCCAGCCAGGTCAATCTTTCTCCATTCAGTATGGAACCGGGAGCTTGTCCGGGATCATTGGAGCCG ACCAAGTCTCTGTGGAAGGACTAACCGTGGTTGGCCAGCAGTTTGGAGAAAGTGTCACAGAGCCAGGCCAGACCTTTGTGGATGCAGAGT TTGATGGAATTCTGGGCCTGGGATACCCCTCCTTGGCTGTGGGAGGAGTGACTCCAGTATTTGACAACATGATGGCTCAGAACCTGGTGG ACTTGCCGATGTTTTCTGTCTACATGAGCAGTAACCCAGAAGGTGGTGCGGGGAGCGAGCTGATTTTTGGAGGCTACGACCACTCCCATT TCTCTGGGAGCCTGAATTGGGTCCCAGTCACCAAGCAAGCTTACTGGCAGATTGCACTGGATAATATGCTGTGGAGTGTGCCAACCTTAA CGTCATGCCGGATGTCACCTTCACCATTAACGGAGTCCCCTATACCCTCAGCCCAACTGCCTACACCCTACTGGACTTCGTGGATGGAAT GCAGTTCTGCAGCAGTGGCTTTCAAGGACTTGACATCCACCCTCCAGCTGGGCCCCTCTGGATCCTGGGGGATGTCTTCATTCGACAGTT TTACTCAGTCTTTGACCGTGGGAATAACCGTGTGGGACTGGCCCCAGCAGTCCCCTAAGGAGGGGCCTTGTGTCTGTGCCTGCCTGTCTG ACAGACCTTGAATATGTTAGGCTGGGGCATTCTTTACACCTACAAAAAGTTATTTTCCAGAGAATGTAGCTGTTTCCAGGGTTGCAACTT GAATTAAGACCAAACAGAACATGAGAATACACACACACACACACATATACACACACACACACTTCACACATACACACCACTCCCACCACC GTCATGATGGAGGAATTACGTTATACATTCATATTTTGTATTGATTTTTGATTATGAAAATCAAAAATTTTCACATTTGATTATGAAAAT >In-frame_ENST00000325558_ENST00000432969_TCGA-BR-8060-11A_PGA3_chr11_60971741_+_CTSE_chr1_206319100_length(amino acids)=379AA_start in transcript=131_stop in transcript=1270 MHLPPVLPSPSSWDPGRTMKWLLLLGLVALSECIMYKVPLIRKKSLRRTLSERGLLKDFLKKHNLNPARKYFPQWKAPTLVDEQPLENYL DMEYFGTISIGSPPQNFTVIFDTGSSNLWVPSVYCTSPACKTHSRFQPSQSSTYSQPGQSFSIQYGTGSLSGIIGADQVSVEGLTVVGQQ FGESVTEPGQTFVDAEFDGILGLGYPSLAVGGVTPVFDNMMAQNLVDLPMFSVYMSSNPEGGAGSELIFGGYDHSHFSGSLNWVPVTKQA YWQIALDNMLWSVPTLTSCRMSPSPLTESPIPSAQLPTPYWTSWMECSSAAVAFKDLTSTLQLGPSGSWGMSSFDSFTQSLTVGITVWDW -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PGA3-CTSE |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PGA3-CTSE |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PGA3-CTSE |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | CTSE | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Tgene | CTSE | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Tgene | CTSE | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Tgene | CTSE | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Tgene | CTSE | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Tgene | CTSE | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Tgene | CTSE | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |